Northwest Biotherapeutics, Inc.
NWBO
$0.2125
-$0.03-12.37%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.30% | -51.80% | 102.32% | -59.97% | -69.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.60% | 29.11% | -34.90% | -25.15% | -18.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.53% | -38.57% | 7.20% | -47.87% | -56.23% |
|
|
|||||
| Total Current Assets | -1.53% | -38.57% | 7.20% | -47.87% | -56.23% |
| Net Property, Plant & Equipment | -5.02% | 5.16% | -2.59% | 1.13% | 9.30% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.11% | 4.76% | 3.05% | 0.28% | 4.64% |
| Total Assets | -4.08% | -6.89% | -0.75% | -13.09% | -11.04% |
|
|
|||||
| Total Accounts Payable | 65.65% | 45.27% | 25.08% | 26.88% | -4.15% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 259.69% | -7.58% | 5.69% | 15.80% | -74.39% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.78% | 52.53% | 876.28% | 4,335.12% | 3,345.81% |
| Total Finance Division Other Current Liabilities | 17.17% | -13.75% | -39.59% | -41.06% | -85.75% |
| Total Other Current Liabilities | 17.17% | -13.75% | -39.59% | -41.06% | -85.75% |
| Total Current Liabilities | 51.04% | 21.01% | 40.70% | 39.66% | -64.13% |
|
|
|||||
| Total Current Liabilities | 51.04% | 21.01% | 40.70% | 39.66% | -64.13% |
| Long-Term Debt | 39.31% | 121.68% | 29.80% | -36.23% | 239.04% |
| Short-term Debt | 259.69% | -7.58% | 5.69% | 15.80% | -74.39% |
| Capital Leases | -0.36% | 16.79% | -0.18% | 0.32% | 1.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -5.05% | 3.30% | 23.46% | -- | -- |
| Total Liabilities | 41.09% | 35.70% | 34.14% | 26.03% | -45.06% |
|
|
|||||
| Common Stock & APIC | 4.14% | 4.93% | 4.60% | 4.26% | 10.85% |
| Retained Earnings | -6.16% | -5.55% | -5.57% | -5.37% | -4.83% |
| Treasury Stock & Other | 103.43% | -103.36% | 18.25% | -10.58% | -52.48% |
| Total Common Equity | -43.66% | -23.03% | -25.34% | -30.91% | 48.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -17.15% | -42.61% | -26.13% | -16.60% | -18.83% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -17.15% | -42.61% | -26.13% | -16.60% | -18.83% |
|
|
|||||
| Total Common Equity | -43.66% | -23.03% | -25.34% | -30.91% | 48.66% |
| Total Preferred Equity | -17.15% | -42.61% | -26.13% | -16.60% | -18.83% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -67.85% | -71.52% | -61.98% | -65.93% | 55.20% |
|
|
|||||